Ad
related to: transplantation
Search results
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KSAN - KLST San Angelo· 2 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European ...
Semaglutide Significantly Improves Chronic Kidney Disease
Medscape· 3 days agoSemaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in...
Worthy Global Advocacy: Sustainable And Equitable Healthcare Delivery
Forbes· 4 days agoThe first is the demonstrations on US college campuses by young people. The second is a recent...
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal...
Centers for Disease Control and Prevention· 4 days agoWe describe an underrecognized Scedosporium spp. and Lomentospora prolificans vascular tropism requiring specific management of which clinicians should be aware.
Roche Holding AG (OTCMKTS:RHHBY) Receives $40.00 Consensus Target Price from Brokerages
ETF DAILY NEWS· 3 days agoRoche Holding AG (OTCMKTS:RHHBY – Get Free Report) has earned an average rating of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat reports. One analyst has ...
Turning the Tide Against Epstein-Barr Virus With Repurposed Drugs
SciTechDaily· 4 days agoThe Epstein-Barr virus (EBV) can cause a spectrum of diseases, including a range of cancers....
Antinephrin Autoantibodies: Biomarker for Kidney Disease?
Medscape· 1 day agoUsing an innovative analysis technique, researchers identified antinephrin autoantibodies as markers...
StemCyte Renews Contract with the California State Umbilical Cord Blood Collection Program
FOX 4 Kansas City· 4 days agoStemCyte, a leader in cord blood-based regenerative therapeutics in Southern California, is excited to announce the renewal of its partnership with the California State Umbilical Cord Blood ...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 3 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
Further CYP-001 GvHD Clinical Data Published in Nature Medicine
The Woonsocket Call· 5 days agoCYP-001 is Cynata's Cymerus™ off-the-shelf iPSC[1]-derived MSC[2] product for intravenous infusion, which is being investigated as a potential immune modulating treatment. Graft versus host ...
